209 related articles for article (PubMed ID: 11596014)
1. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M
Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014
[TBL] [Abstract][Full Text] [Related]
2. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy].
Tsuji T; Hirano T; Yamasaki H; Tuda H
Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
Wells T; Kovacs MJ
Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
[TBL] [Abstract][Full Text] [Related]
5. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
[TBL] [Abstract][Full Text] [Related]
6. [Treatment with cyclosporin A of the anemia associated with chronic lymphatic leukemia].
Rozman M; Montserrat E; Cervantes F; Bladé J; Marín P; Rozman C
Sangre (Barc); 1990 Aug; 35(4):321-5. PubMed ID: 2148838
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine A in chronic lymphocytic leukemia: dual anti-leukemic and immunosuppressive role?
Wright SJ; Keating MJ
Leuk Lymphoma; 1995 Dec; 20(1-2):131-6. PubMed ID: 8750634
[TBL] [Abstract][Full Text] [Related]
8. [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
Telek B; Batár P; Uvardy M
Orv Hetil; 2005 Aug; 146(34):1791-3. PubMed ID: 16184881
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune hemolytic anemia in chronic lymphocytic leukemia patients treated with fludarabine.
Di Raimondo F; Giustolisi R; Cacciola E; O'Brien S; Kantarjian H; Robertson LB; Keating MJ
Leuk Lymphoma; 1993 Sep; 11(1-2):63-8. PubMed ID: 8220155
[TBL] [Abstract][Full Text] [Related]
10. Evan's syndrome precipitated by fludarabine therapy in a case of CLL.
Sen K; Kalaycio M
Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320
[No Abstract] [Full Text] [Related]
11. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
Leach M; Parsons RM; Reilly JT; Winfield DA
Clin Lab Haematol; 2000 Jun; 22(3):175-8. PubMed ID: 10931169
[TBL] [Abstract][Full Text] [Related]
12. Role of splenectomy in chronic lymphocytic leukemia.
Cusack JC; Seymour JF; Lerner S; Keating MJ; Pollock RE
J Am Coll Surg; 1997 Sep; 185(3):237-43. PubMed ID: 9291400
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia.
Bergmann L; Fenchel K; Jahn B; Mitrou PS; Hoelzer D
Ann Oncol; 1993 May; 4(5):371-5. PubMed ID: 8353071
[TBL] [Abstract][Full Text] [Related]
14. Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin.
Shimoni A; Shvidel L; Klepfish A; Shtalrid M; Sigler E; Berrebi A
Leukemia; 1999 Jan; 13(1):142-3. PubMed ID: 10049051
[No Abstract] [Full Text] [Related]
15. Pure red cell aplasia occurring during ibrutinib therapy for chronic lymphocytic leukemia.
Wang L; Wu S; Yu G; Sui X; Chu X; Liu X
J Oncol Pharm Pract; 2023 Dec; 29(8):2031-2036. PubMed ID: 37518980
[TBL] [Abstract][Full Text] [Related]
16. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
Nishida H; Murase T; Ueno H; Park JW; Yano T; Ikeda Y
Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
[TBL] [Abstract][Full Text] [Related]
17. Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
Martell RE; Peterson BL; Cohen HJ; Petros WP; Rai KR; Morrison VA; Elias L; Shepherd L; Hines J; Larson RA; Schiffer CA; Hurwitz HI
Cancer Chemother Pharmacol; 2002 Jul; 50(1):37-45. PubMed ID: 12111110
[TBL] [Abstract][Full Text] [Related]
18. Role of splenectomy in chronic lymphocytic leukaemia with massive splenomegaly and cytopenia.
Majumdar G; Singh AK
Leuk Lymphoma; 1992 May; 7(1-2):131-4. PubMed ID: 1472923
[TBL] [Abstract][Full Text] [Related]
19. Rituximab-cyclophosphamide-dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemia.
Rossignol J; Michallet AS; Oberic L; Picard M; Garon A; Willekens C; Dulery R; Leleu X; Cazin B; Ysebaert L
Leukemia; 2011 Mar; 25(3):473-8. PubMed ID: 21127498
[TBL] [Abstract][Full Text] [Related]
20. Rituximab treatment of refractory fludarabine-associated immune thrombocytopenia in chronic lymphocytic leukemia.
Hegde UP; Wilson WH; White T; Cheson BD
Blood; 2002 Sep; 100(6):2260-2. PubMed ID: 12200396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
